MedPath

The OPTIMA-Ex trial: Osteoporosis Prevention Through Impact and Muscle-loading Approaches to Exercise

Not Applicable
Active, not recruiting
Conditions
ow bone mass
Osteopenia
Osteoporosis
Low bone mass
Musculoskeletal - Osteoporosis
Physical Medicine / Rehabilitation - Other physical medicine / rehabilitation
Registration Number
ACTRN12616001444471
Lead Sponsor
Griffith University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Active, not recruiting
Sex
Female
Target Recruitment
100
Inclusion Criteria

Female
Apparently healthy
With lower than average bone mineral density (hip or spine BMD T-score less than or equal to 0)
Unaccustomed to resistance training and impact loading exercise

Exclusion Criteria

Musculoskeletal or medical conditions affecting the ability to perform high intensity physical activity, , medications or medical conditions known to effect bone health, cancer, uncontrolled cardiovascular disease, greater than 2 X-ray’s in the past 12 months and current participation in a regular exercise program known to influence bone or previous competitive or regular participation (more than 1 x per week for 1 year or one full season) in resistance training or boxing (including other fight sports and martial arts), gymnastics/dance sports (gymnastics, ballet, aerobics, cheerleading), court sports (volleyball, basketball, netball), ball sports (Australian rules, rugby league/union, soccer, touch) or racquet sports (badminton, squash, tennis) over the past 4 years.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bilateral proximal femur (femoral neck, trochanter and total hip regions of interest) bone mineral density and 3D variables determined by Dual-energy X-ray Absorptiometry.[All participants, pre (baseline) and post-intervention (10 months).];Lumbar spine (L2-L4) bone mineral density determined by Dual-energy X-ray Absorptiometry.[All participants, pre (baseline) and post-intervention (10 months).];Whole body bone mineral density determined by Dual-energy X-ray Absorptiometry .[All participants, pre (baseline) and post-intervention (10 months)]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath